Viatris Inc
About
Viatris Inc (NASDAQ:VTRS) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
Apr 10 2026
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Mar 23 2026
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
Mar 19 2026
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
Mar 11 2026
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
Financials
Revenue
$14.3 B
Market Cap
$15.48 B
EPS
-3.00
Dividend Yield
3.52%